Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest

Molecular BioSystems

Volumn 6, Issue 8, 2010, Pages 1503-1509

  Jeong, Kyung Chae ^a   Ahn, Kyung Ohk ^a   Yang, Chul Hak ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; MAX PROTEIN, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HL 60; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENETICS; HUMAN; METABOLISM; MOLECULAR LIBRARY; PATHOLOGY; PHYSIOLOGY; PROMYELOCYTIC LEUKEMIA; TUMOR CELL CULTURE;

APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL CYCLE; CELL PROLIFERATION; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; SMALL MOLECULE LIBRARIES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 77954618278     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c002534h     Document Type: Article

References (40)

1. M. Henriksson B. Luscher Proteins of the Myc network: essential regulators of cell growth and differentiation Adv. Cancer Res. 1996 68 109 82
2. L. M. Facchini L. Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J. 1998 12 9 633 51
3. G. C. Prendergast Mechanisms of apoptosis by c-Myc Oncogene 1999 18 19 2967 87
4. B. M. Iritani R. N. Eisenman c-Myc enhances protein synthesis and cell size during B lymphocyte development Proc. Natl. Acad. Sci. U. S. A. 1999 96 23 13180 5
5. E. M. Blackwood R. N. Eisenman Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 1991 251 4998 1211 7
6. G. C. Prendergast D. Lawe E. B. Ziff Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation Cell 1991 65 3 395 407
7. E. M. Blackwood B. Luscher R. N. Eisenman Myc and Max associate in vivo Genes Dev. 1992 6 1 71 80
8. A. Wenzel C. Cziepluch U. Hamann J. Schurmann M. Schwab The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells Embo J. 1991 10 12 3703 12
9. T. K. Blackwell L. Kretzner E. M. Blackwood R. N. Eisenman H. Weintraub Sequence-specific DNA binding by the c-Myc protein Science 1990 250 4984 1149 51
10. E. Kerkhoff K. Bister K. H. Klempnauer Sequence-specific DNA binding by Myc proteins Proc. Natl. Acad. Sci. U. S. A. 1991 88 10 4323 7
11. C. V. Dang L. M. Resar E. Emison S. Kim Q. Li J. E. Prescott D. Wonsey K. Zeller Function of the c-Myc oncogenic transcription factor Exp. Cell Res. 1999 253 1 63 77
12. B. Amati T. D. Littlewood G. I. Evan H. Land The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max Embo J. 1993 12 13 5083 7
13. M. Guerin M. Barrois M. J. Terrier M. Spielmann G. Riou Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis Oncogene Res 1988 3 1 21 31
14. R. Mariani-Costantini C. Escot C. Theillet A. Gentile G. Merlo R. Lidereau R. Callahan In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast Cancer Res. 1988 48 1 199 205
15. D. A. Spandidos J. K. Field N. J. Agnantis G. I. Evan J. P. Moore High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique Anticancer Res. 1989 9 4 821 6
16. T. H. Rabbitts P. H. Hamlyn R. Baer Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma Nature 1983 306 5945 760 5
17. C. E. Nesbit J. M. Tersak E. V. Prochownik MYC oncogenes and human neoplastic disease Oncogene 1999 18 19 3004 16
18. C. B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 1995 267 5203 1456 62
19. R. A. Kinloch J. M. Treherne L. M. Furness I. Hajimohamadreza The pharmacology of apoptosis Trends Pharmacol. Sci. 1999 20 1 35 42
20. V. M. Dirsch D. S. Antlsperger H. Hentze A. M. Vollmar Ajoene, an experimental anti-leukemic drug: mechanism of cell death Leukemia 2002 16 1 74 83
21. L. Gamet-Payrastre P. Li S. Lumeau G. Cassar M. A. Dupont S. Chevolleau N. Gasc J. Tulliez F. Terce Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells Cancer Res. 2000 60 5 1426 33
22. J. Klucar M. Al-Rubeai G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin FEBS Lett. 1997 400 1 127 30
23. R. Bieker C. Lerchenmuller J. Wehmeyer H. L. Serve R. M. Mesters T. Buchner W. E. Berdel Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia Oncol. Rep. 2003 10 4 915 20
24. M. E. Habel R. Lemieux D. Jung Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression J. Cell. Physiol. 2005 203 1 277 85
25. D. A. Stewart X. Xu S. D. Thomas D. M. Miller Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression Nucleic Acids Res. 2002 30 11 2565 74
26. T. Berg S. B. Cohen J. Desharnais C. Sonderegger D. J. Maslyar J. Goldberg D. L. Boger P. K. Vogt Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts Proc. Natl. Acad. Sci. U. S. A. 2002 99 6 3830 5
27. X. Yin C. Giap J. S. Lazo E. V. Prochownik Low molecular weight inhibitors of Myc-Max interaction and function Oncogene 2003 22 40 6151 9
28. A. Kiessling B. Sperl A. Hollis D. Eick T. Berg Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules Chem. Biol. 2006 13 7 745 51
29. S. J. Collins F. W. Ruscetti R. E. Gallagher R. C. Gallo Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds Proc. Natl. Acad. Sci. U. S. A. 1978 75 5 2458 62
30. K. C. Jung C. H. Park Y. H. Hwang H. S. Rhee J. H. Lee H. K. Kim C. H. Yang Fatty acids, inhibitors for the DNA binding of c-Myc/Max dimer, suppress proliferation and induce apoptosis of differentiated HL-60 human leukemia cell Leukemia 2006 20 1 122 7
31. D. L. Trainer T. Kline F. L. McCabe L. F. Faucette J. Feild M. Chaikin M. Anzano D. Rieman S. Hoffstein D. J. Li, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines Int. J. Cancer 1988 41 2 287 96
32. D. Y. Mao J. D. Watson P. S. Yan D. Barsyte-Lovejoy F. Khosravi W. W. Wong P. J. Farnham T. H. Huang L. Z. Penn Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression Curr. Biol. 2003 13 10 882 6
33. I. Perez-Roger S. H. Kim B. Griffiths A. Sewing H. Land Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1) EMBO J. 1999 18 19 5310 20
34. C. Bouchard K. Thieke A. Maier R. Saffrich J. Hanley-Hyde W. Ansorge S. Reed P. Sicinski J. Bartek M. Eilers Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 EMBO J. 1999 18 19 5321 33
35. C. V. Dang and L. A. Lee, c-Myc Function in Neoplasia, R. G. Landes, Austin, TX, 1995
36. B. R. Stanton A. S. Perkins L. Tessarollo D. A. Sassoon L. F. Parada Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop Genes Dev. 1992 6 12A 2235 47
37. J. Charron B. A. Malynn P. Fisher V. Stewart L. Jeannotte S. P. Goff E. J. Robertson F. W. Alt Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene Genes Dev. 1992 6 12A 2248 57
38. S. Sawai A. Shimono Y. Wakamatsu C. Palmes K. Hanaoka H. Kondoh Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse Development 1993 117 4 1445 55
39. A. C. Davis M. Wims G. D. Spotts S. R. Hann A. Bradley A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice Genes Dev. 1993 7 4 671 82
40. L. Soucek J. Whitfield C. P. Martins A. J. Finch D. J. Murphy N. M. Sodir A. N. Karnezis L. B. Swigart S. Nasi G. I. Evan Modelling Myc inhibition as a cancer therapy Nature 2008 455 7213 679 83